Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. by Olzmann, James et al.
UC Berkeley
UC Berkeley Previously Published Works
Title
Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via 
binding to HDAC6.
Permalink
https://escholarship.org/uc/item/5dv5r8bx
Journal
The Journal of Cell Biology, 178(6)
ISSN
0021-9525
Authors
Olzmann, James
Li, Lian
Chudaev, Maksim
et al.
Publication Date
2007-09-10
DOI
10.1083/jcb.200611128
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press  $30.00
The Journal of Cell Biology, Vol. 178, No. 6, September 10, 2007 1025–1038
http://www.jcb.org/cgi/doi/10.1083/jcb.200611128 JCB 1025
Introduction
A prominent feature common to most neurodegenerative dis-
eases is the accumulation of misfolded proteins in cytoplasmic 
inclusions, such as Lewy bodies in Parkinson’s disease (PD) and 
neurofi brillary tangles in Alzheimer’s disease (AD). The accu-
mulation of misfolded proteins in these diseases most likely oc-
curs due to a chronic imbalance in the generation and clearance 
of misfolded proteins. Misfolded proteins can be generated by 
genetic mutations (Goldberg, 2003) or oxidative modifi cations 
(Dalle-Donne et al., 2006). Misfolded proteins are prone to 
aggregation and have the potential to impair cellular functions 
(Gregersen et al., 2006). Cells combat the buildup of misfolded 
proteins either by chaperone-mediated refolding or by protea-
somal degradation (Goldberg, 2003). Alternatively, when the pro-
teasome becomes overwhelmed or impaired, misfolded proteins 
are transported by the retrograde dynein motor complex to peri-
centriolar inclusions called aggresomes (Johnston et al., 1998; 
Kopito, 2000; Garcia-Mata et al., 2002). It has been proposed 
that aggresome formation is a specifi c and active cellular re-
sponse serving to sequester potentially toxic misfolded proteins 
(Kopito, 2000). Recent evidence suggests that there are similar-
ities between Lewy bodies and aggresomes (Olanow et al., 2004). 
However, the molecular mechanisms involved in recognition and 
targeting of misfolded proteins to aggresomes remain unclear.
Ubiquitination is a dynamic post-translational modifi ca-
tion that serves diverse cellular roles (Weissman, 2001; Pickart 
and Fushman, 2004). Ubiquitin is covalently attached to a sub-
strate protein through the formation of an isopeptide bond 
between the C-terminal glycine residue of ubiquitin and the 
ε-amino group of a lysine residue on the substrate by a cascade 
of enzymatic reactions involving an E1 ubiquitin-activating 
enzyme, an E2 ubiquitin-conjugating enzyme, and an E3 ubiquitin 
protein ligase. Successive conjugation of ubiquitin molecules to 
one of the seven internal lysine residues (K6, K11, K27, K29, 
K33, K48, and K63) within the preceding ubiquitin molecule 
results in formation of a polyubiquitin chain (Pickart and Fushman, 
2004). K48-linked polyubiquitination acts as the canonical signal 
for targeting the substrate to the proteasome for degradation. In 
contrast, K63-linked polyubiquitination has recently been shown 
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to have a proteasome-independent role in the regulation of several 
cellular processes, including endocytosis, signal transduction, 
and DNA damage (Pickart and Fushman, 2004; Haglund and 
Dikic, 2005). Although K48-linked polyubiquitination has been 
extensively studied, relatively little is known about the molecu-
lar mechanisms underlying polyubiquitination via K63 or other 
lysine linkages.
Mutations in the E3 ligase parkin account for 50% of 
all recessively transmitted early-onset PD cases (Kitada et al., 
1998; Lucking et al., 2000; Hattori and Mizuno, 2004). Inter-
estingly, parkin-associated PD is devoid of Lewy bodies 
(Takahashi et al., 1994; Mori et al., 1998; Hayashi et al., 
2000), suggesting that parkin function may be required for the 
formation of these inclusion bodies (Sulzer, 2007). Parkin is 
present in Lewy bodies in sporadic PD (Schlossmacher et al., 
2002) and is recruited to aggresomes in cells treated with pro-
teasome inhibitors (Junn et al., 2002; Ardley et al., 2003; Zhao 
et al., 2003; Muqit et al., 2004). However, the precise role of 
parkin in the biogenesis of Lewy bodies or aggresomes is un-
clear. Two studies suggest that parkin is capable of mediating 
K63-linked polyubiquitination (Doss-Pepe et al., 2005; Lim 
et al., 2005a). However, the cellular role of parkin-mediated 
K63-linked polyubiquitination and the molecular mechanism 
by which parkin mediates K63-linked polyubiquitination re-
main undefi ned.
DJ-1 is a ubiquitously expressed protein that is mutated in 
an autosomal recessive, early-onset form of PD (Abou-Sleiman 
et al., 2003; Bonifati et al., 2003). We and others have previ-
ously shown that the PD-linked L166P mutation disrupts DJ-1 
protein folding, resulting in a misfolded protein that is prone to 
aggregation (Olzmann et al., 2004; Shendelman et al., 2004). 
The folding state of other parkin-interacting proteins has not 
been investigated. Therefore, in this study we investigated the 
role of parkin in ubiquitinating misfolded proteins, using the 
L166P mutant DJ-1 as a model. Our fi ndings reveal a novel 
proteasome-independent role for parkin in the regulation of 
aggresome formation and have important implications for un-
derstanding the biogenesis of Lewy bodies in PD.
Results
Parkin selectively recognizes and 
ubiquitinates L166P mutant DJ-1, 
but not wild-type DJ-1
We and others have previously shown that the L166P mutation-
induced misfolded DJ-1 is selectively polyubiquitinated and 
degraded by the proteasome (Baulac et al., 2004; Olzmann et al., 
2004). The molecular machinery that recognizes and ubiqui-
tinates L166P mutant DJ-1 is unknown. We have proposed that 
L166P mutant DJ-1 might be a substrate for the E3 ligase parkin 
(Olzmann et al., 2004). As shown in Fig. 1, immunoprecipitation 
of hemagglutinin (HA)-tagged L166P mutant DJ-1, but not wild-
type DJ-1, was able to coprecipitate Myc-tagged parkin, provid-
ing evidence for an interaction of these two proteins in vivo 
(Fig. 1 A). Given the reported interaction of Parkin and L166P 
mutant DJ-1 with Hsp70 (Imai et al., 2002; Li et al., 2005; Moore 
et al., 2005), we considered the possibility that these three 
proteins might be present in a complex. However, coimmuno-
precipitation experiments indicated that, even with high levels 
of Hsp70 overexpression, Hsp70 did not associate with L166P 
mutant DJ-1 under the experimental conditions used (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200611128/DC1). 
Furthermore, we found that GST-parkin bound Myc-tagged 
L166P mutant DJ-1 expressed in SH-SY5Y cells, but not Myc-
tagged wild-type DJ-1 or endogenous DJ-1 (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200611128/DC1). In 
addition, GST-parkin was able to effi ciently pull down in vitro 
translated [35S]-labeled L166P mutant DJ-1, but not wild-type 
DJ-1 (Fig. 1 B). Together, our data indicate that parkin directly 
binds L166P mutant DJ-1, but not wild-type DJ-1, and that this 
interaction does not require Hsp70 as a recruiting factor.
Next, we performed in vivo ubiquitination assays to ex-
amine whether the interaction with parkin targets misfolded DJ-1 
for parkin-mediated ubiquitination. In agreement with previous 
reports (Baulac et al., 2004; Olzmann et al., 2004), we found 
that L166P mutant DJ-1, but not wild-type DJ-1, was selectively 
polyubiquitinated in cells (Fig. 1 C). The polyubiquitination of 
L166P mutant DJ-1 was signifi cantly increased by coexpression 
of parkin in the presence of the proteasome inhibitor MG132 
(Fig. 1 C). Under the same conditions, parkin did not promote 
the ubiquitination of wild-type DJ-1 (Fig. 1 C). Together, these 
results demonstrate that parkin selectively recognizes and ubiq-
uitinates misfolded DJ-1 in vivo.
Parkin-mediated polyubiquitination 
has no apparent effect on the 
degradation of misfolded DJ-1
To determine whether parkin-mediated ubiquitination targets 
L166P mutant DJ-1 for degradation by the proteasome, we as-
sessed the effect of parkin overexpression on the steady-state 
levels of wild-type and L166P mutant DJ-1 proteins (Fig. 1 D). 
As we and others reported previously (Miller et al., 2003; 
Moore et al., 2003; Gorner et al., 2004; Olzmann et al., 2004), 
the steady-state level of L166P mutant DJ-1 was substantially 
lower compared with wild-type DJ-1. Inhibition of proteasome 
function by MG132 selectively increased the steady-state level 
of the L166P mutant, but not wild-type DJ-1 (Fig. 1 D). Con-
trary to our expectation, we found that overexpression of parkin 
did not alter the steady-state levels of L166P mutant or wild-
type DJ-1 (Fig. 1 D). Given the recent report that parkin pro-
motes degradation of synphilin-1 only when the expression of 
parkin reaches very high levels (Lim et al., 2005a), we exam-
ined the effects of increased levels of parkin expression on 
the degradation of L166P mutant DJ-1 (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200611128/DC1). Even 
at extremely high levels of overexpression, parkin was unable 
to promote degradation of L166P mutant DJ-1 (Fig. S3). Con-
sistent with our previous fi ndings (Olzmann et al., 2004), pulse 
chase experiments indicated that L166P mutant DJ-1 was highly 
unstable compared with the wild-type DJ-1 (Fig. 1 E). Co-
 expression of parkin had no effect on the stability of L166P 
mutant DJ-1 (Fig. 1 E). Together these results suggest that parkin-
mediated polyubiquitination of mutant DJ-1 may have a non-
degradative role.
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Parkin associates with the heterodimeric 
E2 enzyme UbcH13/Uev1a to mediate K63-
linked polyubiquitination of misfolded DJ-1
One possibility that may account for the inability of parkin to 
promote the degradation of L166P mutant DJ-1 is that parkin 
may mediate an alternative form of polyubiquitination that is 
not associated with proteasomal degradation, such as K63-linked 
polyubiquitination. The best-characterized E2 enzyme in mediat-
ing K63-linked polyubiquitination is the UbcH13/Uev1a heterodi-
mer, in which UbcH13 is the catalytic subunit (Deng et al., 2000; 
Figure 1. Selective interaction and ubiquitination of L166P mutant DJ-1 by parkin. (A) Lysates from transfected SH-SY5Y cells were subjected to immuno-
precipitation with anti-HA antibody followed by Western blotting. endo., endogenous; IB, immunoblot; IP, immunoprecipitation. (B) [35S]-labeled DJ-1 pro-
teins were incubated with immobilized GST or GST-parkin fusion proteins. Bound DJ-1 proteins were detected by autoradiography. (C) Transfected SH-SY5Y 
cells were incubated in the absence or presence of 20 μM proteasome inhibitor MG132 for 8 h before harvest. Lysates were subjected to immunoprecipita-
tion with anti-Myc antibody followed by Western blotting. The expression of parkin in the cell lysates is confi rmed by immunoblotting with anti-parkin anti-
body. Ubn, polyubiquitin. (D) Lysates from MG132 (20 μM)- or vehicle (0.1% DMSO)-treated SH-SY5Y cells transfected with the indicated plasmids were 
analyzed by Western blotting. The relative level of wild-type or mutant DJ-1 was measured by quantifi cation of the intensity of the HA-tagged DJ-1 or L166P 
band and normalized to the actin level in the corresponding cell lysate. The bar graph shows the results (mean ± SEM) from at least three independent 
experiments. (E) The half-life of Myc-tagged wild-type and L166P mutant DJ-1 expressed in SH-SY5Y cells was analyzed by pulse chase and the protein levels 
quantifi ed and plotted relative to the corresponding DJ-1 levels at 0 h.
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Wang et al., 2001). A recent in vitro study has shown that the 
GST-fused second RING domain of parkin can bind UbcH13 
and this interaction recruits the UbcH13/Uev1a heterodimer to 
parkin (Doss-Pepe et al., 2005). However, it is unknown whether 
full-length parkin is able to bind UbcH13 in vivo. As shown 
(Fig. 2 A), UbcH13 readily coprecipitated with parkin, providing 
evidence for an interaction between these two proteins in vivo. 
In addition, we observed the interaction of parkin with UbcH7 
and UbcH8, but not with UbcH5, consistent with previous stud-
ies (Shimura et al., 2000; Zhang et al., 2000). These data indi-
cate that parkin binds multiple E2 enzymes in vivo and suggest 
that the ability of parkin to facilitate K48- or K63-linked poly-
ubiquitination may be dependent on the selective recruitment 
of distinct E2 enzymes.
We next performed in vitro ubiquitination assays to deter-
mine if the UbcH13/Uev1a heterodimer is the cognate E2 en-
zyme for parkin-mediated ubiquitination of L166P mutant DJ-1. 
We found that parkin ubiquitinated L166P mutant DJ-1 in an 
UbcH13/Uev1a-dependent manner (Fig. 2 B). To investigate 
the linkage of parkin-mediated polyubiquitination of L166P 
mutant DJ-1, we used ubiquitin mutants Ub-K29, Ub-K48, and 
Ub-K63, which contain arginine substitutions of all of its lysine 
residues except the one at position 29, 48, and 63, respectively. 
The Ub-K29, Ub-K48, and Ub-K63 mutants are thus expected 
to only allow the formation of K29-, K48-, and K63-linked 
polyubiquitin chains, respectively. In vitro ubiquitination ana-
lyses using these ubiquitin mutants revealed that parkin was 
able to facilitate the polyubiquitination of L166P mutant DJ-1 
in the presence of wild-type ubiquitin (Ub-WT) and Ub-K63 
(Fig. 2 C). In contrast, in vitro ubiquitination reactions using 
Ub-K29 or Ub-K48 resulted in the accumulation of monoubiq-
uitinated L166P mutant DJ-1 (Fig. 2 C). In addition, low levels 
of higher molecular weight bands were also observed at sizes 
corresponding to L166P mutant DJ-1 conjugated with three or 
four ubiquitin molecules (Fig. 2 C), and these bands could po-
tentially represent monoubiquitination of L166P mutant DJ-1 at 
multiple lysine residues. Together these results demonstrate that 
parkin-mediated polyubiquitination of L166P mutant DJ-1 oc-
curs in vitro via K63-linked ubiquitin chains.
We then used Ub-K48 and Ub-K63 mutants in in vivo ubiq-
uitination assays to determine the linkage of parkin-mediated 
polyubiquitination of L166P mutant DJ-1 in cells (Fig. 3 A). 
In agreement with the results of the in vitro ubiquitination anal-
ysis (Fig. 2 C), parkin promoted robust polyubiquitination of 
L166P mutant DJ-1 in cells expressing Ub-WT or Ub-K63, but 
not in cells expressing Ub-K48 (Fig. 3 A). To provide further 
support for the identifi ed K63 linkage of parkin-mediated poly-
ubiquitination of L166P mutant DJ-1, we used another set of 
ubiquitin mutants, Ub-K29R, Ub-K48R, Ub-K63R, which con-
tain a single lysine-to-arginine mutation at position 29, 48, and 
63, respectively. The Ub-K29R, Ub-K48R, and Ub-K63R mu-
tants are expected to solely disrupt the assembly of K29-, K48-, 
and K63-linked polyubiquitin chains, respectively. As a control, 
we also included a polymerization-defective mutant of ubiqui-
tin (Ub-K0), in which all lysine residues of ubiquitin were 
changed to arginines, and therefore is unable to form polyubiq-
uitin chains. We found that parkin-mediated polyubiquitination 
of L166P mutant DJ-1 was greatly reduced by replacement 
of Ub-WT with Ub-K63R, but not by the replacement with 
Ub-K29R (Fig. 3 B). As expected, parkin-mediated polyubiqui-
tination of L166P mutant DJ-1 was virtually abolished by re-
placement of Ub-WT with Ub-K0 (Fig. 3, A and B). The low 
levels of L166P mutant DJ-1 ubiquitination observed with Ub-
K63R could be due to non-K63-linked ubiquitination of mutant 
Figure 2. Parkin mediates K63-linked polyubiq-
uitination of L166P mutant DJ-1 in cooperation 
with the UbcH13/Uev1a E2 enzyme. (A) Lysates 
from transfected SH-SY5Y cells were subjected to 
immunoprecipitation with anti-Myc antibody fol-
lowed by Western blotting. (B and C) Purifi ed 
L166P mutant DJ-1 was subjected to in vitro ubiq-
uitination in the presence of E1, E2 (UbcH13/
Uev1a), GST-tagged parkin, and wild-type or mutant 
ubiquitin as indicated. Ubiquitinated mutant DJ-1 
was detected by immunoblotting with anti-DJ-1 anti-
body. All experiments were replicated three times 
with similar results.
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DJ-1 by another E3 ubiquitin-protein ligase(s) in SH-SY5Y cells. 
Consistent with this possibility, we found that the polyubiqui-
tination of L166P mutant DJ-1 was reduced by replacement 
of Ub-WT with Ub-K48R mutant (Fig. 3 B). Furthermore, we 
and others have previously shown that L166P mutant DJ-1 as-
sociates with the E3 ligase CHIP (Moore et al., 2005; Olzmann 
et al., 2005). Collectively, our in vitro and in vivo data pro-
vide strong evidence that parkin facilitates K63-linked poly-
ubiquitination of L166P mutant DJ-1 in cooperation with 
UbcH13/Uev1a.
L166P mutant DJ-1 and parkin 
colocalize in aggresomes induced 
by proteasome impairment
Our fi ndings that parkin specifi cally binds and ubiquitinates 
L166P mutant DJ-1 prompted us to investigate the potential co-
localization of these two proteins in SH-SY5Y cells by immuno-
fl uorescence confocal microscopy. HA-tagged L166P mutant 
DJ-1 exhibited a cytoplasmic staining pattern that displayed sub-
stantial overlap with that of Myc-tagged parkin (Fig. 4 A, top). 
In addition, treatment with the proteasome inhibitor MG132 
caused a dramatic relocation of L166P mutant DJ-1 and parkin 
to a single prominent, perinuclear inclusion (Fig. 4 A, bottom).
The morphology and localization of the L166P mutant 
DJ-1–containing inclusions appeared similar to that of aggresomes 
(Johnston et al., 1998; Kopito, 2000; Garcia-Mata et al., 2002). To 
test whether these inclusions were aggresomes, we performed 
additional immunofl uorescence confocal microscopy experi-
ments to further characterize these inclusions (Fig. 4 B). We found 
that the L166P mutant DJ-1-containing inclusions were highly 
enriched with ubiquitin and the chaperone protein Hsp70, and 
surrounded by a compacted cage of the intermediate fi lament pro-
tein vimentin. Lamp2-immunoreactive lysosomes did not co-
lo calize with the inclusions, but were observed in close apposition 
and often tightly ringed the inclusions. This fi nding is consistent 
with recent studies indicating that aggresomes may represent sub-
strates for autophagic degradation, a process involving fusion with 
lysosomes (Taylor et al., 2003). Moreover, serial 1-μm Z-sections 
revealed that the misfolded DJ-1 protein was present throughout 
the center of the aggresome, extensively colocalized with ubiq-
uitin, and completely surrounded by vimentin (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200611128/DC1).
Given the reported role of microtubule-dependent retro-
grade transport in aggresome formation (Kopito, 2000), we 
examined the effects of the microtubule-depolymerizing drug 
nocodazole on parkin-induced recruitment of L166P mutant 
DJ-1 to aggresomes (Fig. 4 A). Depolymerization of micro-
tubules by nocodazole in MG132-treated cells disrupted delivery 
of L166P mutant DJ-1 to the aggresome, leading to accumula-
tion of misfolded DJ-1 in widely dispersed preaggresome parti-
cles (Fig. 4 A). Parkin colocalized with L166P mutant DJ-1 in 
these preaggresome particles (Fig. 4 A), demonstrating an asso-
ciation of these two proteins before their transport to the ag-
gresome. Together, these data indicate that recruitment of L166P 
mutant DJ-1 to the aggresome is dependent on intact micro-
tubules and that the inclusions containing L166P mutant DJ-1 are 
bona fi de aggresomes.
Accumulating evidence indicates that aggresomes found 
in cultured cells are substrates for eventual autophagic degra-
dation. To determine if L166P mutant DJ-1-containing ag-
gresomes are sites of autophagy we used the widely used 
marker of autophagic vacuoles monodansyl cadaverine (MDC) 
(Biederbick et al., 1995; Jackson et al., 2005) (Fig. S5, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200611128/DC1). 
The specificity of MDC staining is further confirmed by our 
results, which show that MDC staining does not overlap with 
lamp2 (Fig. S5), a protein present on late endosomes and lyso-
somes. Our findings indicate that under control conditions 
Figure 3. Parkin promotes K63-linked polyubiquitination of L166P mutant DJ-1 in vivo. (A and B) Transfected SH-SY5Y cells were treated with 20 μM 
MG132 for 8 h before harvest. Lysates (input) were subjected to immunoprecipitation with anti-Myc antibody followed by Western blotting. IgG HC, immuno-
globulin heavy chain; IgG LC, immunoglobulin light chain.
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MDC displays a widely distributed, punctate distribution with 
relatively low fl uorescence levels (Fig. S5). However, MG132-
induced proteasomal impairment results in an increase in MDC 
fl uorescence levels and a redistribution of MDC immuno-
reactivity to a perinuclear region that colocalizes with the L166P 
mutant DJ-1 aggresomes (Fig. S5). Together these findings 
indicate that L166P mutant DJ-1 aggresomes may be sites 
of autophagy.
Parkin selectively promotes 
the recruitment of L166P mutant DJ-1, 
but not wild-type DJ-1, to aggresomes
To determine whether parkin selectively targets L166P mutant 
DJ-1 to aggresomes, we assessed the effects of parkin overex-
pression on the accumulation of HA-tagged wild-type and L166P 
mutant DJ-1 in aggresomes formed in response to proteasome 
inhibition by MG132 (Fig. 5). In untreated cells the coexpression 
Figure 4. Colocalization of L166P mutant DJ-1 
and parkin in perinuclear aggresomes. (A) SH-
SY5Y cells coexpressing Myc-tagged parkin and 
HA-tagged L166P mutant DJ-1 were incubated in 
DME containing 0.1% DMSO, 20 μM MG132, 
20 μM MG132 plus 5 μg/ml nocodazole for 
16 h as indicated. In cells treated with MG132 a 
prominent L166P mutant DJ-1–containing aggre-
some is evident (arrowhead). However, cotreatment 
with nocodazole results in the accumulation of 
L166P mutant DJ-1–containing micro-aggregates 
(open arrowheads). (B) For further analysis of inclu-
sions, SH-SY5Y cells coexpressing GFP-tagged par-
kin and Myc-tagged L166P were incubated in the 
presence of 20 μM MG132 for 16 h and sub-
sequently processed for immunocytochemistry with 
the indicated antibodies. The colocalization be-
tween parkin and L166P mutant DJ-1 is indicated 
by the yellow color. The colocalization of parkin, 
L166P mutant DJ-1, and ubiquitin or hsp70 is indi-
cated by the white color. Bar = 10 μm.
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of parkin had no effect on the cytoplasmic distribution of wild-
type or L166P mutant DJ-1 (Fig. 5, A and B). Treatment of the 
cells with MG132 did not alter the distribution of wild-type 
DJ-1, but caused the accumulation of L166P mutant DJ-1 in 
aggresomes in a small percentage of cells (Fig. 5, C and E). 
Interestingly, coexpression of parkin resulted in a dramatic in-
crease in the percentage of cells containing L166P mutant DJ-1–
positive aggresomes, but had no effect on the localization of 
wild-type DJ-1 (Fig. 5, D and E).
Aggresomes contain misfolded and aggregated proteins, 
and are often insoluble in detergents (Johnston et al., 2002). 
To determine if recruitment of L166P mutant DJ-1 to these 
aggresomes alters its solubility, cell lysates were separated into 
detergent soluble and insoluble fractions, and analyzed by West-
ern blotting. Wild-type and L166P mutant DJ-1 were predomi-
nantly found in the soluble fraction in untreated cells (Fig. 6, 
A and B). However, MG132 treatment resulted in the selective 
accumulation of L166P mutant DJ-1 in the detergent insoluble 
fraction, and this accumulation was increased by coexpression 
of parkin (Fig. 6, A and B). These results demonstrate that par-
kin selectively promotes the redistribution of misfolded DJ-1 
into a detergent-insoluble aggresome.
Figure 5. Parkin promotes the accumulation of L166P mutant DJ-1 in aggresomes. (A–D) SH-SY5Y cells coexpressing HA-tagged wild-type DJ-1 or L166P 
mutant DJ-1 and Myc vector or Myc-tagged parkin were incubated in the presence and absence of 20 μM MG132 for 16 h and processed for immuno-
fl uorescence with anti-HA (red) and anti-Myc (green) antibodies. (A and B) In untreated cells HA-tagged wild-type DJ-1 and L166P mutant DJ-1 are distributed 
throughout the cytoplasm and colocalize with Myc-tagged parkin. (C and D) Inhibition of the proteasome coupled with overexpression of parkin resulted 
in the accumulation of L166P mutant DJ-1 in aggresomes (arrowheads). In cells that were not transfected with parkin L166P mutant DJ-1 mostly retained a 
diffuse distribution (open arrowheads). In contrast, the distribution of wild-type DJ-1 was unaffected, although these cells displayed robust parkin-containing 
aggresomes (arrowheads). Superimposed images revealed a colocalization (yellow) between L166P mutant DJ-1 and parkin in the perinuclear region 
in the presence of MG132. Bar = 10 μm. (E) Quantifi cation shows that parkin selectively increases the targeting of L166P mutant DJ-1 to aggresomes. 
The asterisk indicates statistical signifi cance (P < 0.05).
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Parkin-mediated K63-linked 
polyubiquitination facilitates 
the formation of aggresomes
To investigate the role of parkin-mediated K63-linked polyubiq-
uitination in aggresome formation, we analyzed and com-
pared the formation of MG132-induced aggresomes in SH-SY5Y 
cells coexpressing L166P mutant DJ-1 and Myc-tagged parkin 
in the presence of either HA-tagged Ub-WT, Ub-K48, Ub-K63, 
Ub-K48R, or Ub-K63R. We observed the presence of a clearly 
visible aggresome containing immunoreactivity to HA-tagged 
ubiquitin and L166P mutant DJ-1 in most of the cells express-
ing Ub-WT (46%) after 16-h MG132 treatment (Fig. 7, A and B). 
Replacement of Ub-WT with Ub-K63R dramatically reduced 
aggresome formation and resulted in the accumulation of cyto-
plasmic preaggresomal particles, whereas replacement with 
Ub-K48R had no apparent effect (Fig. 7, A and B). Moreover, 
expression of Ub-K63 signifi cantly enhanced aggresome for-
mation compared with cells expressing Ub-K48, which were 
more likely to contain cytoplasmic preaggresomal particles 
(Fig. 7, A and B). Together, our results suggest that K63-linked 
polyubiquitination of misfolded DJ-1 by parkin promotes 
aggresome formation.
Parkin-mediated K63-linked 
polyubiquitination of misfolded DJ-1 
serves as a signal for binding HDAC6
The observed microtubule-dependent recruitment of L166P mu-
tant DJ-1 to the aggresome (Fig. 4) suggests that the retrograde 
dynein motor complex may be involved in the transport of mis-
folded DJ-1. Recent evidence indicates that histone deacetylase 6 
(HDAC6) is critically involved in aggresome formation by act-
ing as an adaptor between polyubiquitinated proteins and the 
dynein motor complex (Kawaguchi et al., 2003; Hideshima 
et al., 2005). We performed coimmunoprecipitation analyses 
to examine a potential interaction between Myc-tagged L166P 
mutant DJ-1 and endogenous HDAC6. We found that HDAC6 
does not bind nonubiquitinated L166P mutant DJ-1 in untreated 
cells (Fig. 8 A). In contrast, HDAC6 strongly interacts with 
polyubiquitinated L166P mutant DJ-1 induced by parkin coexpres-
sion in MG132-treated cells (Fig. 8 A). Moreover, immunofl uores-
cence confocal microscopic studies revealed that, in response to 
Figure 6. Parkin increases the insolubility of L166P mutant, but not wild-
type DJ-1. (A), Lysates from transfected SH-SY5Y cells were separated into 
detergent-soluble (S) and detergent-insoluble (I) fractions and analyzed by 
Western blotting. (B) The relative level of insoluble DJ-1 was measured by 
quantifi cation of the intensity of the HA-tagged DJ-1 or L166P band in the 
detergent-insoluble fraction and normalized to the total level of HA-tagged 
wild-type or mutant DJ-1 in the corresponding cell lysate. The asterisk indi-
cates a statistically signifi cant (P < 0.05) difference compared with the 
corresponding control.
Figure 7. Parkin-mediated K63 polyubiquitination promotes the forma-
tion of L166P mutant DJ-1 aggresomes. (A) SH-SY5Y cells coexpressing 
GFP-tagged parkin, Myc-tagged L166P mutant DJ-1, and the indicated HA-
tagged ubiquitin mutants were incubated in the presence of 20 μM MG132 
for 16 h, fi xed, and immunostained with antibodies against Myc (green) 
and HA (purple). Bar = 10 μm. (B) The percentage of cells containing 
L166P mutant DJ-1-positive aggresomes was quantifi ed from 50–100 trans-
fected cells and indicates that K63-linked polyubiquitination is important for 
the targeting of the misfolded protein to aggresomes. The asterisk indicates 
a statistically signifi cant decrease (P < 0.05) in the percentage of cells con-
taining aggresomes in cells expressing HA-tagged Ub-K48 or Ub-K63R 
versus the cells expressing HA-tagged Ub-WT, Ub-K63, or Ub-K48R.
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proteasome inhibition, both HDAC6 and dynein are recruited 
with L166P mutant DJ-1 to aggresomes (Fig. 8 B).
Although HDAC6 has been shown to bind polyubiqui-
tinated proteins (Hook et al., 2002; Kawaguchi et al., 2003), it 
remains unknown whether HDAC6 specifi cally binds K48-
linked and/or K63-linked polyubiquitin chains. Coimmuno-
precipitation studies in SH-SY5Y cells expressing HA-tagged 
Ub-K48 or Ub-K63 indicate that HDAC6 interacts with both 
K48- and K63-linked polyubiquitin chains, but binds more 
strongly to K63-linked chains (Fig. 8 C), providing evidence 
that HDAC6 preferentially interacts with K63-linked poly-
ubiquitinated proteins in vivo. Together, these data suggest that 
parkin-mediated K63-linked polyubiquitination of L166P mu-
tant DJ-1 serves as a signal for binding HDAC6, and thus couples 
the misfolded DJ-1 to the dynein motor complex for transport to 
the aggresome.
Parkin is required for delivery of misfolded 
DJ-1 to aggresomes
Given our fi ndings that parkin-mediated K63-linked polyu-
biquitination mediates the recognition of misfolded DJ-1 by 
HDAC6 and the dynein motor complex (Figs. 5, 7, and 8), we 
Figure 8. Parkin-mediated K63-linked polyubiq-
uitination of L166P mutant DJ-1 promotes an asso-
ciation with HDAC6. (A) Lysates from transfected 
SH-SY5Y cells incubated in the absence or presence 
of MG132 were subjected to immunoprecipita-
tion with anti-Myc antibodies followed by Western 
blotting. (B) SH-SY5Y cells coexpressing GFP-tagged 
parkin and HA-tagged L166P mutant DJ-1 were in-
cubated in the presence and absence of MG132, 
immunostained as indicated, and imaged by 
 immunofl uorescence confocal microscopy. Bar = 
10 μm. (C) Lysates from transfected SH-SY5Y cells 
were subjected to immunoprecipitation with anti-
HA antibodies and analyzed by Western blotting.
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next assessed the role of parkin in the transport of misfolded 
proteins to the aggresome using mouse embryonic fi broblasts 
(MEFs) cultured from Parkin knockout (Parkin−/−) mice (Perez 
et al., 2005; Perez and Palmiter, 2005). Western blot analysis 
with anti-parkin antibodies confi rmed the absence of parkin pro-
tein in Parkin−/− MEFs (Fig. 9 A). In addition, pulse chase anal-
ysis indicated that the absence of parkin had no effect on the 
stability of L166P mutant DJ-1 (Fig. 9 B). Immunofl uorescence 
confocal microscopy showed that L166P mutant DJ-1 exhibited 
a diffuse cytoplasmic distribution in both untreated Parkin+/+ 
and Parkin−/− MEFs (unpublished data). In Parkin+/+ MEFs 
treated with MG132, L166P mutant DJ-1 accumulated in ag-
gresomes (Fig. 9, C and D). In contrast, in Parkin−/− MEFs, 
Myc-tagged L166P mutant DJ-1 was mostly observed in small 
preaggresomal particles dispersed throughout the cytoplasm 
(Fig. 9, B and C). Furthermore, coexpression of untagged-parkin 
rescued the ability of Parkin−/− MEFs to properly target the 
misfolded DJ-1 to aggresomes (Fig. 9, C and D). Together these 
results indicate that parkin is critically involved in the transport 
of misfolded DJ-1 to aggresomes.
Discussion
Although it is clear that cells sequester misfolded proteins into 
centrosomal aggresomes, how the cell recognizes these proteins 
for transport to the aggresome is poorly understood. Our fi nd-
ings support the model depicted in Fig. 10, and suggest that 
misfolded proteins are normally polyubiquitinated and effi -
ciently degraded by the 26S proteasome. However, under patho-
genic conditions in which proteasome function is impaired, 
parkin cooperates with UbcH13/Uev1a to mediate K63-linked 
polyubiquitination of misfolded proteins, promotes binding of 
HDAC6 and couples the misfolded protein to the dynein motor 
complex for transport to aggresomes.
Our results demonstrate that parkin directly binds the 
misfolded L166P mutant, but not wild-type DJ-1. We fi nd that 
parkin selectively promotes K63-linked polyubiquitination of 
L166P mutant DJ-1 in an UbcH13/Uev1a-dependent manner. 
K63-linked polyubiquitination has been proposed to play a role 
in the formation of inclusion bodies (Lim et al., 2005b), but the 
underlying molecular mechanisms remain unknown. Our data 
show that parkin promotes the accumulation of misfolded DJ-1 
into aggresomes. Furthermore, the ability of parkin to promote 
the sequestration of misfolded DJ-1 into aggresomes is depen-
dent on K63-linked polyubiquitination, and expression of 
Ub-K48 or Ub-K63R results in the accumulation of small 
 preaggresomal particles dispersed throughout the cytoplasm. 
Previous studies suggest that misfolded proteins form small ag-
gregates within the cytoplasm, which are then transported to the 
forming aggresome (Kopito, 2000; Garcia-Mata et al., 2002). 
Disruption of transport by incubation with nocodazole (Johnston 
et al., 1998), overexpression of dynamitin (Garcia-Mata et al., 1999; 
Johnston et al., 2002), siRNA-mediated depletion (Kawaguchi 
et al., 2003), or chemical inhibition (Wang et al., 2005) of 
Figure 9. Parkin is required for proper transport 
of misfolded proteins to aggresomes. (A) Lysates 
from MEFs cultured from Parkin−/− and Parkin+/+ 
were separated by SDS-PAGE and analyzed by 
Western blotting. (B) The half-life of Myc-tagged 
L166P mutant DJ-1 expressed in Parkin−/− and 
Parkin+/+ MEFs was analyzed by pulse chase and 
the protein levels quantifi ed and plotted relative to 
the corresponding levels at 0 h. (C) Parkin−/− and 
Parkin+/+ MEFs were transfected with Myc-tagged 
L166P mutant DJ-1 and untagged-parkin as indi-
cated, treated with 20 μM MG132 for 16 h, and 
processed for immunocytochemistry with anti-Myc 
(green) antibodies. Bar = 10 μm. (D) The percent-
age of cells containing L166P mutant DJ-1 ag-
gresomes was quantifi ed from 50–100 transfected 
cells. The asterisk indicates a statistically signifi -
cant difference (P < 0.05).
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HDAC6 results in the accumulation of small cytoplasmic ag-
gregates. Thus the preaggresomal particles that accumulate 
upon expression of Ub-K48 or Ub-K63R may represent L166P 
mutant DJ-1-containing small aggregates. In addition to L166P 
mutant DJ-1, these preaggresomal particles also contained parkin, 
which suggests that K63-linked polyubiquitination may be im-
portant for the transport of parkin to the aggresome. Hampe 
et al. reported that parkin catalyzes multi-monoubiquitination of 
itself (auto-ubiquitination) in vitro and a fraction of parkin is 
multi-monoubiquitinated in vivo under basal conditions (Hampe 
et al., 2006). However, under conditions of proteasomal impair-
ment, they found that parkin is mostly polyubiquitinated in vivo 
(Hampe et al., 2006), which might be mediated by another E3 li-
gase or by parkin in cooperation with additional factor(s) such as 
E4 (Imai et al., 2002; Richly et al., 2005). Furthermore, Lim 
et al. reported that parkin is modifi ed by K63-linked polyubiqui-
tination in vivo, which was suggested to be mediated by parkin 
itself (Lim et al., 2005a). K63-linked polyubiquitination of par-
kin under conditions of proteasomal impairment would promote 
the transport of parkin to aggresomes, and this could explain the 
reduced formation of parkin-positive aggresomes when K63-
linked polyubiquitination was inhibited.
One possibility is that K63-linked polyubiquitination may 
block K48-linked polyubiquitination, resulting in decreased 
proteasomal degradation and increased substrate accumulation. 
However, this does not address how these proteins are recog-
nized and targeted to the aggresome. Our results indicate that 
K63-linked polyubiquitination plays an active signaling role, 
and that under conditions of proteasomal impairment facilitates 
an interaction between L166P mutant DJ-1 and the dynein adap-
tor protein HDAC6. HDAC6 links polyubiquitinated proteins, to 
the molecular motor dynein by simultaneously binding ubiqui-
tin via a zinc-fi nger ubiquitin binding domain and dynein via a 
distinct dynein motor binding domain (Kawaguchi et al., 2003). 
In addition, HDAC6 has been found to localize to Lewy bodies 
in sporadic PD patients, suggesting that HDAC6 may also play 
a similar role in the biogenesis of these hallmark PD inclusions. 
Our results further demonstrate that HDAC6 preferentially binds 
K63-linked polyubiquitinated proteins in vivo, suggesting that 
K63-linked polyubiquitination may act as a novel signal for the 
dynein-mediated transport and sequestration of misfolded pro-
teins in the aggresome.
Based on the localization of parkin in aggresomes/ 
inclusions, it has been proposed that parkin is fi rst recruited to 
aggresomes in response to proteasome inhibition and then 
ubiquitinates misfolded proteins in these inclusion bodies (Lim 
et al., 2005a). In this case, one would expect that targeting of 
misfolded proteins to aggresomes in Parkin−/− MEFs would be 
unaffected, but that there would be a decrease in the ubiquitina-
tion of the inclusions. However, we observed that the percentage 
of cells containing L166P mutant DJ-1 aggresomes was dramat-
ically reduced in Parkin−/− MEFs. These fi ndings support a role 
for parkin in the transport of misfolded DJ-1 to aggresomes 
rather than in the ubiquitination of the misfolded proteins in 
aggresomes. In addition, when transport of misfolded proteins 
to the aggresome was disrupted with nocodazole we observed 
that parkin colocalized with misfolded DJ-1 in ubiquitin-positive, 
preaggresomal particles, suggesting that parkin associates with 
and polyubiquitinates misfolded proteins before their transport 
to aggresomes.
Whether protein inclusions are cytoprotective or cytotoxic 
is highly controversial. Studies indicate that several intermedi-
ates are generated during the process of protein aggregation, and 
suggest that the small-intermediate oligomers may be the principle 
toxic species (Caughey and Lansbury, 2003). Accumulation of 
aggregated proteins can cause global impairment of the ubiqui-
tin-proteasome system (Bence et al., 2001; Bennett et al., 2005) 
and aggregated proteins also directly interfere with proteasomal 
function, possibly due to an inability to properly enter or exit the 
proteasome (Holmberg et al., 2004; Venkatraman et al., 2004; 
Kristiansen et al., 2007). Sequestration into inclusions like 
aggresomes may render these oligomers inert and protect an im-
paired proteasomal system from further damage. Interestingly, 
recent evidence suggests that aggresomes might also act as a 
staging area for disposal by autophagy (Taylor et al., 2003). In 
support of this possibility, we fi nd that L166P mutant DJ-1 ag-
gresomes stained with MDC, a marker of autophagic vacuoles. 
Figure 10. Model of parkin-dependent targeting of misfolded proteins to 
the aggresome. Under normal conditions misfolded proteins are recognized 
and conjugated with K48-linked polyubiquitin chains, resulting in effi cient 
degradation by the 26S proteasome. However, under conditions of protea-
somal impairment, parkin cooperates with Ubc13/Uev1a to mediate K63-
linked polyubiquitination of misfolded proteins. This K63-linked polyubiquitin 
chain promotes binding of the dynein adaptor protein HDAC6, which 
effectively “loads” the misfolded protein onto the dynein motor complex 
for retrograde transport along microtubules to aggresomes.
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Consistent with the fi ndings of Iwata et al. (Iwata et al., 2005), 
we observed that MG132-mediated inhibition of the proteasome 
resulted in a redistribution of lysosomes, and often lysosomes 
tightly encircled the aggresome. A protective role for aggresomes 
has been further supported by the fi nding that disruption of ag-
gresome formation using small molecule inhibitors of HDAC6 
(Hideshima et al., 2005) or by knockdown of HDAC6 protein 
levels by RNA interference (Kawaguchi et al., 2003) increases 
the susceptibility to apoptosis induced by proteasome inhibition 
or misfolded protein stress.
It is widely believed that loss of parkin function would 
lead to decreased proteasomal degradation of a cytotoxic sub-
strate protein, resulting in selective dopaminergic neurodegen-
eration (Kahle and Haass, 2004). Studies have found that Parkin 
promotes the proteasomal degradation of several putative sub-
strate proteins (Kahle and Haass, 2004). However, the accumu-
lation of these substrates in parkin knockout mouse brain and 
human PD brains has been confl icting (Goldberg et al., 2003; 
Ko et al., 2005, 2006; Periquet et al., 2005). Thus the role these 
substrates play in the pathogenesis of PD remains to be deter-
mined. Recent reports indicate that parkin is able to mediate 
monoubiquitination (Hampe et al., 2006; Matsuda et al., 2006) 
and K63-linked polyubiquitination (Doss-Pepe et al., 2005; Lim 
et al., 2005a; Fig. 2 and 3), two forms of ubiquitination that are 
not associated with proteasomal degradation. In addition, parkin 
has been implicated in nonproteasomal processes, including 
endocytosis and signal transduction (Fallon et al., 2006). Our 
fi ndings further indicate that parkin plays a regulatory role in 
traffi cking of misfolded DJ-1 to aggresomes. Our data reveal a 
critical role for parkin-mediated K63 polyubiquitination in ear-
marking misfolded proteins for dynein-mediated transport to 
the aggresome and suggest that loss of parkin function may 
impair sequestration of toxic misfolded proteins, thereby result-
ing in an increased susceptibility to aggregated protein-induced 
cellular dysfunction.
Materials and methods
Plasmids and antibodies
The expression vectors encoding HA- and Myc-tagged wild-type and 
L166P mutant DJ-1 were described previously (Olzmann et al., 2004). 
Myc-tagged parkin and HA-tagged UbcH13 were provided by T. Suzuki 
(Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan) and 
Z. Chen (University of Texas Southwestern, Dallas, TX), respectively. HA-
tagged Ub-WT, Ub-K48, Ub-K63, and Ub-K0 were provided by T. Dawson 
(Johns Hopkins University, Baltimore, MD); and Ub-K29R, Ub-K48R, and 
Ub-K63R were provided by M. Wooten (Auburn University, Auburn, AL). 
Anti–DJ-1 antibodies P7F and P7C were described previously (Olzmann 
et al., 2004, 2007). Other antibodies used in this study include the 
 following: anti-HA (12CA5), anti-Myc (9E10.3, Neomarkers), anti-parkin 
(Cell Signaling), anti-Hsp70 (Stressgen), anti-ubiquitin (P4G7, Covance), 
anti-vimentin (Sigma-Aldrich), anti–β-tubulin (Boehringer Mannheim), 
anti-HDAC6 (Santa Cruz Biotechnology, Inc.), anti-lamp2 (Iowa Develop-
mental Studies Hybridoma Bank), and anti-dynein (Sigma-Aldrich); all 
secondary antibodies were purchased from Jackson ImmunoResearch 
Laboratories, Inc.
Cell transfections and immunoprecipitation
SH-SY5Y cells and mouse embryonic fi broblasts (MEFs) were transfected 
with the indicated plasmids using Lipofectamine 2000 (Invitrogen) or TransIt-
Neural (Mirus), respectively, according to the manufacturer’s instructions. 
Cell lysates were prepared from transfected cells and immunoprecipitations 
performed as described previously (Olzmann et al., 2004).
Recombinant protein purifi cation and in vitro binding assays
GST-tagged parkin fusion proteins were expressed in Escherichia coli BL21 
cells and affi nity purifi ed as described previously (Chin et al., 2002; Kim 
et al., 2007). Immobilized GST or GST-Parkin (5 μg) were incubated with 
[35S]Methionine-labeled Myc-tagged DJ-1 or L166P mutant DJ-1, generated 
using the TNT Quick Coupled Transcription/Translation System (Promega), 
in phosphate buffered saline for 2 h at 4°C. After extensive washes, bound 
proteins were separated by SDS-PAGE and visualized by autoradiography.
Analysis of steady-state protein levels
Transfected SH-SY5Y cells were incubated for 8 h at 37°C with the protea-
some inhibitor MG132 (20 μM, Calbiochem) or vehicle dimethyl sulfoxide 
(DMSO, fi nal concentration 0.1%) and protein levels analyzed as described 
previously (Olzmann et al., 2004).
[35S]Methionine pulse-chase experiments
As described previously (Olzmann et al., 2004), transfected SH-SY5Y cells 
or MEFs were labeled by incubation with Met/Cys-free DME (Invitrogen) 
containing 100 μCi of Met/Cys Tran35S-label (MP Biomedicals) for 1 h. 
Cells were washed and then incubated with DME containing 5 the nor-
mal concentrations of methionine and cysteine. At the indicated chase 
times, equal amount of proteins were immunoprecipitated with anti-Myc 
antibody, separated by SDS-PAGE, and analyzed by autoradiography.
In vitro and in vivo ubiquitination assays
In vitro ubiquitination assays were performed using a well-established re-
constitution system (Shimura et al., 2000, 2001; Pridgeon et al., 2003). In 
brief, L166P mutant DJ-1 was purifi ed as described previously (Olzmann 
et al., 2004). 1.5 μg of purifi ed L166P mutant DJ-1 was incubated at 37°C 
in 60 μl of reaction buffer (50 mM Tris-HCl, pH 7.5, 2.5 mM MgCl2, 2 mM 
DTT, and 2 mM ATP) containing 200 ng of E1 (Boston Biochem), 400 ng 
of E2 ubiquitin-conjugating enzyme (UbcH13/Uev1a) (Boston Biochem), 
1.5 μg of purifi ed GST-tagged parkin, and 10 μg ubiquitin or ubiquitin 
mutants (Boston Biochem). After incubation for 2 h the reaction was stopped 
by addition of loading buffer. Reaction products were analyzed by immuno-
blotting with anti-DJ-1 antibody to detect ubiquitin-conjugated DJ-1 proteins. 
In vivo ubiquitination assays were performed as described previously 
(Wheeler et al., 2002; Olzmann et al., 2004).
Cell fractionation
Transfected SH-SY5Y cells were lysed in a buffer containing 50 mM Tris-
HCl pH 7.6, 150 mM NaCl, 1.0% Triton X-100, and a cocktail of protease 
inhibitors. Lysates were centrifuged at 100,000 g for 30 min at 4°C and 
separated into detergent-soluble and insoluble fractions as described (Junn 
et al., 2002). Fractions were analyzed by Western blotting, and protein 
levels quantifi ed using Scion Image. An ANOVA with a Tukey’s posthoc 
test was used for statistical comparison.
Immunofl uorescence confocal microscopy
SH-SY5Y cells or MEFs were processed and stained as previously described 
(Chin et al., 2000). Hoechst 33258 (Molecular Probes) was used to stain 
 nuclei. MDC (Sigma-Aldrich) staining and costaining was performed as de-
scribed (Jackson et al., 2005). Analysis and acquisition was performed using 
a confocal laser-scanning microscope (Axiovert 100 M; Carl Zeiss Micro-
Imaging, Inc.) with a 63×, 1.4 NA, oil-immersion objective (Carl Zeiss 
MicroImaging, Inc.) at room temperature. Images were exported in TIFF format 
using LSM-510 software (Carl Zeiss MicroImaging, Inc.), and Adobe Photo-
shop Version 7.0 software was used to adjust the contrast and brightness.
Parkin knockout mice and generation of mouse embryonic fi broblasts
Parkin knockout mice, containing a targeted deletion of exon 2, were gen-
erated on a coisogenic background (129S4/SvJaeSor) and characterized 
as described previously (Pawlyk et al., 2003; Perez et al., 2005; Perez 
and Palmiter, 2005). MEF cultures were prepared using well-established 
methods (Bi et al., 2004; Ma et al., 2004). Early passage MEFs were used 
for all experiments.
Analysis of aggresome formation
Transfected SH-SY5Y cells or MEFs were incubated in the presence and 
absence of 20 μM MG132 for 16 h, and then processed for immunofl uor-
escence microscopic analysis of aggresome formation. An aggresome was 
defi ned as a single, perinuclear inclusion containing L166P mutant DJ-1. 
For each experiment, 50–100 transfected cells were randomly selected 
and scored for the presence of an aggresome in a blinded manner. Experi-
ments were repeated three times, and the data were subjected to statistical 
analysis by ANOVA with a Tukey’s posthoc test.
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Online supplemental material
Figure S1 shows how L166P mutant DJ-1 and parkin are not in a complex 
with Hsp70. Figure S2 shows that Parkin selectively pulls down L166P mu-
tant DJ-1, but not wild-type DJ-1. Figure S3 shows how high levels of parkin 
overexpression have no effect on the degradation of L166P mutant DJ-1. Figure 
S4 shoes that the misfolded L166P mutant DJ-1 colocalizes with ubiquitin 
and is concentrated in the center of the aggresome. Figure S5 shows how 
L166P mutant DJ-1-containing aggresomes stain with the autophagosomal-
marker monodansyl cadaverine. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200611128/DC1.
We thank Drs. Zhijian Chen, Toshiaki Suzuki, Ted Dawson, and Marie Wooten 
for providing plasmids.
This work was supported by National Institutes of Health grants 
NS054597 (to J.A. Olzmann), NS050650 (to L.-S. Chin), AG021489 (to L. Li), 
and NS047199 (to L. Li).
Submitted: 22 November 2006
Accepted: 9 August 2007
References
Abou-Sleiman, P.M., D.G. Healy, N. Quinn, A.J. Lees, and N.W. Wood. 2003. 
The role of pathogenic DJ-1 mutations in Parkinson’s disease. Ann. 
Neurol. 54:283–286.
Ardley, H.C., G.B. Scott, S.A. Rose, N.G. Tan, A.F. Markham, and P.A. 
Robinson. 2003. Inhibition of proteasomal activity causes inclusion for-
mation in neuronal and non-neuronal cells overexpressing Parkin. Mol. 
Biol. Cell. 14:4541–4556.
Baulac, S., M.J. LaVoie, J. Strahle, M.G. Schlossmacher, and W. Xia. 2004. 
Dimerization of Parkinson’s disease-causing DJ-1 and formation of 
high molecular weight complexes in human brain. Mol. Cell. Neurosci. 
27:236–246.
Bence, N.F., R.M. Sampat, and R.R. Kopito. 2001. Impairment of the ubiquitin-
proteasome system by protein aggregation. Science. 292:1552–1555.
Bennett, E.J., N.F. Bence, R. Jayakumar, and R.R. Kopito. 2005. Global im-
pairment of the ubiquitin-proteasome system by nuclear or cytoplas-
mic protein aggregates precedes inclusion body formation. Mol. Cell. 
17:351–365.
Bi, Y., R.D. Palmiter, K.M. Wood, and Q. Ma. 2004. Induction of metallothionein I 
by phenolic antioxidants requires metal-activated transcription factor 1 
(MTF-1) and zinc. Biochem. J. 380:695–703.
Biederbick, A., H.F. Kern, and H.P. Elsasser. 1995. Monodansylcadaverine 
(MDC) is a specifi c in vivo marker for autophagic vacuoles. Eur. J. Cell 
Biol. 66:3–14.
Bonifati, V., P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, E. Krieger, 
M.C. Dekker, F. Squitieri, P. Ibanez, M. Joosse, et al. 2003. Mutations in the 
DJ-1 gene associated with autosomal recessive early-onset parkin sonism. 
Science. 299:256–259.
Caughey, B., and P.T. Lansbury. 2003. Protofi brils, pores, fi brils, and neuro-
degeneration: separating the responsible protein aggregates from the inno-
cent bystanders. Annu. Rev. Neurosci. 26:267–298.
Chin, L.S., R.D. Nugent, M.C. Raynor, J.P. Vavalle, and L. Li. 2000. SNIP, a 
novel SNAP-25-interacting protein implicated in regulated exocytosis. 
J. Biol. Chem. 275:1191–1200.
Chin, L.S., J.P. Vavalle, and L. Li. 2002. Staring, a novel E3 ubiquitin-
protein ligase that targets syntaxin 1 for degradation. J. Biol. Chem. 
277:35071–35079.
Dalle-Donne, I., G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani. 
2006. Protein carbonylation, cellular dysfunction, and disease progression. 
J. Cell. Mol. Med. 10:389–406.
Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. 
Pickart, and Z.J. Chen. 2000. Activation of the IkappaB kinase complex 
by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and 
a unique polyubiquitin chain. Cell. 103:351–361.
Doss-Pepe, E.W., L. Chen, and K. Madura. 2005. Alpha-synuclein and parkin 
contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin 
chains. J. Biol. Chem. 280:16619–16624.
Fallon, L., C.M. Belanger, A.T. Corera, M. Kontogiannea, E. Regan-Klapisz, 
F. Moreau, J. Voortman, M. Haber, G. Rouleau, T. Thorarinsdottir, et al. 
2006. A regulated interaction with the UIM protein Eps15 implicates par-
kin in EGF receptor traffi cking and PI(3)K-Akt signalling. Nat. Cell Biol. 
8:834–842.
Garcia-Mata, R., Z. Bebok, E.J. Sorscher, and E.S. Sztul. 1999. Characteriza-
tion and dynamics of aggresome formation by a cytosolic GFP-chimera. 
J. Cell Biol. 146:1239–1254.
Garcia-Mata, R., Y.S. Gao, and E. Sztul. 2002. Hassles with taking out the 
garbage: aggravating aggresomes. Traffi c. 3:388–396.
Goldberg, A.L. 2003. Protein degradation and protection against misfolded or 
damaged proteins. Nature. 426:895–899.
Goldberg, M.S., S.M. Fleming, J.J. Palacino, C. Cepeda, H.A. Lam, A. Bhatnagar, 
E.G. Meloni, N. Wu, L.C. Ackerson, G.J. Klapstein, et al. 2003. Parkin-
defi cient mice exhibit nigrostriatal defi cits but not loss of dopaminergic 
neurons. J. Biol. Chem. 278:43628–43635.
Gorner, K., E. Holtorf, S. Odoy, B. Nuscher, A. Yamamoto, J.T. Regula, K. 
Beyer, C. Haass, and P.J. Kahle. 2004. Differential effects of Parkinson’s 
disease-associated mutations on stability and folding of DJ-1. J. Biol. 
Chem. 279:6943–6951.
Gregersen, N., P. Bross, S. Vang, and J.H. Christensen. 2006. Protein misfolding 
and human disease. Annu. Rev. Genomics Hum. Genet. 7:103–124.
Haglund, K., and I. Dikic. 2005. Ubiquitylation and cell signaling. EMBO J. 
24:3353–3359.
Hampe, C., H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti. 2006. 
Biochemical analysis of Parkinson’s disease-causing variants of Parkin, 
an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum. 
Mol. Genet. 15:2059–2075.
Hattori, N., and Y. Mizuno. 2004. Pathogenetic mechanisms of parkin in 
Parkinson’s disease. Lancet. 364:722–724.
Hayashi, S., K. Wakabayashi, A. Ishikawa, H. Nagai, M. Saito, M. Maruyama, T. 
Takahashi, T. Ozawa, S. Tsuji, and H. Takahashi. 2000. An autopsy case 
of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 
deletion in the parkin gene. Mov. Disord. 15:884–888.
Hideshima, T., J.E. Bradner, J. Wong, D. Chauhan, P. Richardson, S.L. Schreiber, 
and K.C. Anderson. 2005. Small-molecule inhibition of proteasome and 
aggresome function induces synergistic antitumor activity in multiple 
myeloma. Proc. Natl. Acad. Sci. USA. 102:8567–8572.
Holmberg, C.I., K.E. Staniszewski, K.N. Mensah, A. Matouschek, and R.I. 
Morimoto. 2004. Ineffi cient degradation of truncated polyglutamine pro-
teins by the proteasome. EMBO J. 23:4307–4318.
Hook, S.S., A. Orian, S.M. Cowley, and R.N. Eisenman. 2002. Histone deacety-
lase 6 binds polyubiquitin through its zinc fi nger (PAZ domain) and 
copurifi es with deubiquitinating enzymes. Proc. Natl. Acad. Sci. USA. 
99:13425–13430.
Imai, Y., M. Soda, S. Hatakeyama, T. Akagi, T. Hashikawa, K.I. Nakayama, and 
R. Takahashi. 2002. CHIP is associated with Parkin, a gene responsible 
for familial Parkinson’s disease, and enhances its ubiquitin ligase activity. 
Mol. Cell. 10:55–67.
Iwata, A., B.E. Riley, J.A. Johnston, and R.R. Kopito. 2005. HDAC6 and micro-
tubules are required for autophagic degradation of aggregated huntingtin. 
J. Biol. Chem. 280:40282–40292.
Jackson, W.T., T.H. Giddings Jr., M.P. Taylor, S. Mulinyawe, M. Rabinovitch, 
R.R. Kopito, and K. Kirkegaard. 2005. Subversion of cellular autophago-
somal machinery by RNA viruses. PLoS Biol. 3:e156.
Johnston, J.A., C.L. Ward, and R.R. Kopito. 1998. Aggresomes: a cellular 
response to misfolded proteins. J. Cell Biol. 143:1883–1898.
Johnston, J.A., M.E. Illing, and R.R. Kopito. 2002. Cytoplasmic dynein/ 
dynactin mediates the assembly of aggresomes. Cell Motil. Cytoskeleton. 
53:26–38.
Junn, E., S.S. Lee, U.T. Suhr, and M.M. Mouradian. 2002. Parkin accumu-
lation in aggresomes due to proteasome impairment. J. Biol. Chem. 
277:47870–47877.
Kahle, P.J., and C. Haass. 2004. How does parkin ligate ubiquitin to Parkinson’s 
disease? EMBO Rep. 5:681–685.
Kawaguchi, Y., J.J. Kovacs, A. McLaurin, J.M. Vance, A. Ito, and T.P. Yao. 2003. 
The deacetylase HDAC6 regulates aggresome formation and cell viability 
in response to misfolded protein stress. Cell. 115:727–738.
Kim, B.Y., J.A. Olzmann, G.S. Barsh, L.S. Chin, and L. Li. 2007. Spongiform 
neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 
and regulates endosomal traffi cking. Mol. Biol. Cell. 18:1129–1142.
Kitada, T., S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, 
M. Yokochi, Y. Mizuno, and N. Shimizu. 1998. Mutations in the par-
kin gene cause autosomal recessive juvenile parkinsonism. Nature. 
392:605–608.
Ko, H.S., R. von Coelln, S.R. Sriram, S.W. Kim, K.K. Chung, O. Pletnikova, J. 
Troncoso, B. Johnson, R. Saffary, E.L. Goh, et al. 2005. Accumulation 
of the authentic parkin substrate aminoacyl-tRNA synthetase cofac-
tor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 
25:7968–7978.
Ko, H.S., S.W. Kim, S.R. Sriram, V.L. Dawson, and T.M. Dawson. 2006. 
Identifi cation of far upstream element-binding protein-1 as an authentic 
Parkin substrate. J. Biol. Chem. 281:16193–16196.
Kopito, R.R. 2000. Aggresomes, inclusion bodies and protein aggregation. 
Trends Cell Biol. 10:524–530.
JCB • VOLUME 178 • NUMBER 6 • 2007 1038
Kristiansen, M., P. Deriziotis, D.E. Dimcheff, G.S. Jackson, H. Ovaa, H. 
Naumann, A.R. Clarke, F.W.B. van Leeuwen, V. Menendez-Benito, N.P. 
Dantuma, et al. 2007. Disease-associated prion protein oligomers inhibit 
the 26S proteasome. Mol. Cell. 26:175–188.
Li, H.M., T. Niki, T. Taira, S.M. Iguchi-Ariga, and H. Ariga. 2005. Association 
of DJ-1 with chaperones and enhanced association and colocaliza-
tion with mitochondrial Hsp70 by oxidative stress. Free Radic. Res. 
39:1091–1099.
Lim, K.L., K.C. Chew, J.M. Tan, C. Wang, K.K. Chung, Y. Zhang, Y. Tanaka, 
W. Smith, S. Engelender, C.A. Ross, et al. 2005a. Parkin mediates non-
classical, proteasomal-independent ubiquitination of synphilin-1: impli-
cations for Lewy body formation. J. Neurosci. 25:2002–2009.
Lim, K.L., V.L. Dawson, and T.M. Dawson. 2005b. Parkin-mediated lysine 
63-linked polyubiquitination: a link to protein inclusions formation 
in Parkinson’s and other conformational diseases? Neurobiol. Aging. 
27:524–529.
Lucking, C.B., A. Durr, V. Bonifati, J. Vaughan, G. De Michele, T. Gasser, 
B.S. Harhangi, G. Meco, P. Denefl e, N.W. Wood, et al. 2000. Association 
between early-onset Parkinson’s disease and mutations in the parkin 
gene. French Parkinson’s Disease Genetics Study Group. N. Engl. J. Med. 
342:1560–1567.
Ma, Q., K. Kinneer, Y. Bi, J.Y. Chan, and Y.W. Kan. 2004. Induction of murine 
NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-
dioxin requires the CNC (cap ‘n’ collar) basic leucine zipper transcription 
factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction 
between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. 
Biochem. J. 377:205–213.
Matsuda, N., T. Kitami, T. Suzuki, Y. Mizuno, N. Hattori, and K. Tanaka. 2006. 
Diverse effects of pathogenic mutations of Parkin that catalyze multiple 
monoubiquitylation in vitro. J. Biol. Chem. 281:3204–3209.
Miller, D.W., R. Ahmad, S. Hague, M.J. Baptista, R. Canet-Aviles, C. McLendon, 
D.M. Carter, P.P. Zhu, J. Stadler, J. Chandran, et al. 2003. L166P mutant 
DJ-1, causative for recessive Parkinson’s disease, is degraded through the 
ubiquitin-proteasome system. J. Biol. Chem. 278:36588–36595.
Moore, D.J., L. Zhang, T.M. Dawson, and V.L. Dawson. 2003. A missense muta-
tion (L166P) in DJ-1, linked to familial Parkinson’s disease, confers re-
duced protein stability and impairs homo-oligomerization. J. Neurochem. 
87:1558–1567.
Moore, D.J., L. Zhang, J. Troncoso, M.K. Lee, N. Hattori, Y. Mizuno, T.M. Dawson, 
and V.L. Dawson. 2005. Association of DJ-1 and parkin mediated by patho-
genic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14:71–84.
Mori, H., T. Kondo, M. Yokochi, H. Matsumine, Y. Nakagawa-Hattori, T. Miyake, 
K. Suda, and Y. Mizuno. 1998. Pathologic and biochemical studies of 
juvenile parkinsonism linked to chromosome 6q. Neurology. 51:890–892.
Muqit, M.M., S.M. Davidson, M.D. Payne Smith, L.P. MacCormac, S. Kahns, 
P.H. Jensen, N.W. Wood, and D.S. Latchman. 2004. Parkin is recruited 
into aggresomes in a stress-specifi c manner: over-expression of parkin 
reduces aggresome formation but can be dissociated from parkin’s effect 
on neuronal survival. Hum. Mol. Genet. 13:117–135.
Olanow, C.W., D.P. Perl, G.N. DeMartino, and K.S. McNaught. 2004. Lewy-
body formation is an aggresome-related process: a hypothesis. Lancet 
Neurol. 3:496–503.
Olzmann, J.A., K. Brown, K.D. Wilkinson, H.D. Rees, Q. Huai, H. Ke, A.I. 
Levey, L. Li, and L.S. Chin. 2004. Familial Parkinson’s disease-associated 
L166P mutation disrupts DJ-1 protein folding and function. J. Biol. 
Chem. 279:8506–8515.
Olzmann, J.A., J. Pridgeon, L. Li, and L.S. Chin. 2005. CHIP ubiquitinates 
Parkinson’s disease-associated L166P mutant DJ-1 in a chaperone-
independent manner. In American Society for Cell Biology, San Francisco. 
Abstr. 2143.
Olzmann, J.A., J.R. Bordelon, E.C. Muly, H.D. Rees, A.I. Levey, L. Li, and L.S. 
Chin. 2007. Selective enrichment of DJ-1 protein in primate striatal neu-
ronal processes: implications for Parkinson’s disease. J. Comp. Neurol. 
500:585–599.
Pawlyk, A.C., B.I. Giasson, D.M. Sampathu, F.A. Perez, K.L. Lim, V.L. Dawson, 
T.M. Dawson, R.D. Palmiter, J.Q. Trojanowski, and V.M. Lee. 2003. 
Novel monoclonal antibodies demonstrate biochemical variation of brain 
parkin with age. J. Biol. Chem. 278:48120–48128.
Perez, F.A., and R.D. Palmiter. 2005. Parkin-defi cient mice are not a robust 
model of parkinsonism. Proc. Natl. Acad. Sci. USA. 102:2174–2179.
Perez, F.A., W.R. Curtis, and R.D. Palmiter. 2005. Parkin-defi cient mice are not 
more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. 
BMC Neurosci. 6:71.
Periquet, M., O. Corti, S. Jacquier, and A. Brice. 2005. Proteomic analysis of 
parkin knockout mice: alterations in energy metabolism, protein handling 
and synaptic function. J. Neurochem. 95:1259–1276.
Pickart, C.M., and D. Fushman. 2004. Polyubiquitin chains: polymeric protein 
signals. Curr. Opin. Chem. Biol. 8:610–616.
Pridgeon, J.W., T. Geetha, and M.W. Wooten. 2003. A method to identify p62’s 
UBA domain interacting proteins. Biol. Proced. Online. 5:228–237.
Richly, H., M. Rape, S. Braun, S. Rumpf, C. Hoege, and S. Jentsch. 2005. A 
series of ubiquitin binding factors connects CDC48/p97 to substrate multi-
ubiquitylation and proteasomal targeting. Cell. 120:73–84.
Schlossmacher, M.G., M.P. Frosch, W.P. Gai, M. Medina, N. Sharma, L. Forno, 
T. Ochiishi, H. Shimura, R. Sharon, N. Hattori, et al. 2002. Parkin local-
izes to the Lewy bodies of Parkinson disease and dementia with Lewy 
bodies. Am. J. Pathol. 160:1655–1667.
Shendelman, S., A. Jonason, C. Martinat, T. Leete, and A. Abeliovich. 2004. DJ-1 
is a redox-dependent molecular chaperone that inhibits alpha-synuclein 
aggregate formation. PLoS Biol. 2:e362.
Shimura, H., N. Hattori, S. Kubo, Y. Mizuno, S. Asakawa, S. Minoshima, N. 
Shimizu, K. Iwai, T. Chiba, K. Tanaka, and T. Suzuki. 2000. Familial 
Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. 
Genet. 25:302–305.
Shimura, H., M.G. Schlossmacher, N. Hattori, M.P. Frosch, A. Trockenbacher, 
R. Schneider, Y. Mizuno, K.S. Kosik, and D.J. Selkoe. 2001. Ubiquitination 
of a new form of alpha-synuclein by parkin from human brain: implica-
tions for Parkinson’s disease. Science. 293:263–269.
Sulzer, D. 2007. Multiple hit hypotheses for dopamine neuron loss in Parkinson’s 
disease. Trends Neurosci. 30:244–250.
Takahashi, H., E. Ohama, S. Suzuki, Y. Horikawa, A. Ishikawa, T. Morita, S. 
Tsuji, and F. Ikuta. 1994. Familial juvenile parkinsonism: clinical and 
pathologic study in a family. Neurology. 44:437–441.
Taylor, J.P., F. Tanaka, J. Robitschek, C.M. Sandoval, A. Taye, S. Markovic-
Plese, and K.H. Fischbeck. 2003. Aggresomes protect cells by enhancing 
the degradation of toxic polyglutamine-containing protein. Hum. Mol. 
Genet. 12:749–757.
Venkatraman, P., R. Wetzel, M. Tanaka, N. Nukina, and A.L. Goldberg. 2004. 
Eukaryotic proteasomes cannot digest polyglutamine sequences and 
release them during degradation of polyglutamine-containing proteins. 
Mol. Cell. 14:95–104.
Wang, C., L. Deng, M. Hong, G.R. Akkaraju, J. Inoue, and Z.J. Chen. 2001. 
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 
412:346–351.
Wang, L., T.V. Nguyen, R.W. McLaughlin, L.A. Sikkink, M. Ramirez-Alvarado, 
and R.M. Weinshilboum. 2005. Human thiopurine S-methyltransferase 
pharmacogenetics: variant allozyme misfolding and aggresome formation. 
Proc. Natl. Acad. Sci. USA. 102:9394–9399.
Weissman, A.M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. 
Cell Biol. 2:169–178.
Wheeler, T.C., L.S. Chin, Y. Li, F.L. Roudabush, and L. Li. 2002. Regulation of 
synaptophysin degradation by mammalian homologues of seven in 
absentia. J. Biol. Chem. 277:10273–10282.
Zhang, Y., J. Gao, K.K. Chung, H. Huang, V.L. Dawson, and T.M. Dawson. 
2000. Parkin functions as an E2-dependent ubiquitin-protein ligase and 
promotes the degradation of the synaptic vesicle-associated protein, 
CDCrel-1. Proc. Natl. Acad. Sci. USA. 97:13354–13359.
Zhao, J., Y. Ren, Q. Jiang, and J. Feng. 2003. Parkin is recruited to the centrosome 
in response to inhibition of proteasomes. J. Cell Sci. 116:4011–4019.
